HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ankit Kansagra Selected Research
Ankit Kansagra Research Topics
Disease
15
Multiple Myeloma
10/2023 - 01/2018
8
Neoplasms (Cancer)
11/2023 - 01/2012
6
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2021
4
Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 11/2020
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2020 - 01/2017
2
Leukemia
05/2021 - 01/2020
1
Hematologic Diseases (Blood Diseases)
01/2023
1
POEMS Syndrome (Syndrome, POEMS)
12/2022
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
02/2022
1
Immunoglobulin Light-chain Amyloidosis
01/2022
1
Disease Progression
01/2022
1
COVID-19
11/2020
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2020
1
Lymphoma (Lymphomas)
01/2020
1
Nemaline Myopathies (Nemaline Myopathy)
01/2019
1
Bites and Stings (Sting)
01/2018
1
Anemia
11/2017
1
Graft vs Host Disease (Graft-Versus-Host Disease)
09/2017
1
Infections
09/2017
1
Hypothermia
12/2013
1
Acute Kidney Injury (Acute Renal Failure)
12/2013
1
Kidney Diseases (Kidney Disease)
12/2013
1
Gastroenteritis
12/2013
1
Chronic Renal Insufficiency
12/2013
1
Renal Insufficiency (Renal Failure)
12/2013
1
Dehydration (Water Stress)
12/2013
1
Bradycardia
11/2013
1
Tumor Lysis Syndrome
01/2012
Drug/Important Bio-Agent (IBA)
6
Chimeric Antigen Receptors
IBA
10/2023 - 01/2018
6
Monoclonal Antibodies
IBA
01/2022 - 01/2019
3
B-Cell Maturation Antigen
IBA
10/2023 - 01/2022
2
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
01/2023 - 01/2022
2
belantamab mafodotin
IBA
01/2023 - 01/2022
2
Proteasome Inhibitors
IBA
01/2022 - 01/2022
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 01/2021
2
Immunoglobulins (Immunoglobulin)
IBA
05/2021 - 01/2021
2
Leukocyte Immunoglobulin-like Receptor B1
IBA
01/2021 - 01/2020
2
daratumumab
IBA
04/2020 - 01/2019
2
Proteins (Proteins, Gene)
FDA Link
04/2020 - 01/2019
1
idecabtagene vicleucel
IBA
10/2023
1
Immunoconjugates (Immunoconjugate)
IBA
01/2023
1
Imides
IBA
01/2022
1
Lenalidomide (CC 5013)
FDA Link
01/2022
1
elotuzumab
IBA
01/2022
1
carfilzomib
IBA
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022
1
selinexor
IBA
01/2021
1
Myeloma Proteins
IBA
11/2020
1
Antibodies
IBA
11/2020
1
Immunoglobulin G (IgG)
IBA
04/2020
1
Immune Checkpoint Inhibitors
IBA
01/2020
1
isatuximab
IBA
01/2019
1
Tranexamic Acid (AMCA)
FDA Link
11/2017
1
Infliximab (Remicade)
FDA Link
09/2017
1
Steroids
IBA
09/2017
1
Olanzapine (Zyprexa)
FDA Link
12/2013
1
Glycopyrrolate (Glycopyrronium Bromide)
FDA Link
Generic
11/2013
Therapy/Procedure
14
Therapeutics
10/2023 - 01/2016
9
Cell Transplantation
11/2023 - 09/2017
3
Drug Therapy (Chemotherapy)
11/2023 - 01/2012
3
Transplantation
01/2023 - 11/2019
3
Artificial Respiration (Mechanical Ventilation)
01/2017 - 11/2013
2
Immunotherapy
01/2021 - 01/2020
2
Tracheostomy
01/2017 - 01/2016
2
Critical Care (Surgical Intensive Care)
01/2017 - 01/2016
2
Gastrostomy
01/2017 - 01/2016
2
Total Parenteral Nutrition
01/2017 - 01/2016
1
Autologous Transplantation
02/2022
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1
Aftercare (After-Treatment)
01/2020
1
Stem Cell Transplantation
10/2018
1
Salvage Therapy
01/2018
1
Arthroplasty
11/2017
1
Erythrocyte Transfusion
11/2017
1
Premedication
11/2013